US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

101.06

-2.8701-2.76%

Volume:10.58K

Turnover:1.07M

Market Cap:121.27M

PE:- -

High:104.53

Open:104.53

Low:100.91

Close:103.93

52wk High:110.05

52wk Low:68.05

Shares:1.20M

Float Shares:1.20M

Volume Ratio:1.35

T/O Rate:0.88%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development

AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit

Press Release: Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Alvotech to Report Financial Results for H1 2026

Bio-Gene Technology Seeks ASX Quotation for 15.2 Million New Shares

Grail announces FDA advisory committee meeting to review Galleri test PMA

U.K. Short-Dated Sovereign Bonds Look More Attractive than Eurozone Peers

Trump says rates should drop but it's not entirely up to Warsh

Ryan Chua / Bloomberg

ArborGen cancels CEO long-term incentive shares after departure

Biogen completes acquisition of RayThera

U.S. Interest Rates Could Stay Elevated Due to Heavy Debt Issuance

Circio’s circVec gene therapy platform secures oral slot at top European ESGCT conference

Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1

Kevin Warsh has little to say about interest rates. But he has plenty to say about AI

Radiopharm Theranostics Lifts Cap on Securities Purchase Plan to AUD10 Million

Actinogen Medical Seeks ASX Quotation for 3.5 Million Incentive Shares

Circio Strengthens Board With RNA Therapy Veterans Ahead of Clinical Push

Fed's Paulson says she keeps an 'open mind' on interest rates

Maria Eloisa Capurro / Bloomberg

Eikon Therapeutics Announces Recent Board Director Resignations

Fresenius announces FDA approval of rituximab biosimilar

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BBP/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":101.06,"timestamp":1789499202409,"preClose":103.9301,"halted":0,"volume":10584,"delay":0,"changeRate":-0.027615676305516822,"floatShares":1200004,"shares":1200004,"eps":0,"marketStatus":"Trading","change":-2.8701,"latestTime":"09-15 15:08:59 EDT","open":104.53,"high":104.53,"low":100.905,"amount":1072279.0638,"amplitude":0.034879,"askPrice":102.08,"askSize":100,"bidPrice":100.04,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.9301,"sharesOutstanding":600004,"nav":103.362,"aum":124035301.07,"bidAskSpread":0.00263,"preHourTrading":{"tag":"盘前","latestPrice":103.9301,"preClose":103.9301,"latestTime":"07:02 EDT","volume":1,"amount":103.9301,"timestamp":1789470128746,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":103.9499,"preClose":103.9301,"latestTime":"19:30 EDT","volume":11,"amount":1143.2311,"timestamp":1789428605785,"change":0.0198,"changeRate":0.000191,"amplitude":0},"volumeRatio":1.353011,"impliedVol":0.2197,"impliedVolPercentile":0.3865},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1200004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.353011,"shares":1200004,"dividePrice":0,"high":104.53,"amplitude":0.034879,"preClose":103.9301,"low":100.905,"week52Low":68.046,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":101.06,"eps":0,"divideRate":0,"volume":10584,"delay":0,"ttmEps":0,"open":104.53,"prevYearClose":79.9149,"prevWeekClose":103.4597,"prevMonthClose":106.46,"prevQuarterClose":96.2686,"fiveDayClose":106.7132,"twentyDayClose":102.7277,"sixtyDayClose":90.012},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1174341976","title":"Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1174341976","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174341976?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:08","pubTimestamp":1786450094,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) has issued a stock trading risk warning announcement, stating that it is a CRO enterprise primarily focused on the research and development of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GDOC","600721","XLVI","LFSC","IBB","BK4585","BK0102","BIOY","APXH","BK0216","GSKH","PBE","BBP","SBIO","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118729610","title":"AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=1118729610","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118729610?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:12","pubTimestamp":1786428745,"startTime":"0","endTime":"0","summary":"A research report from Orient Securities Company Limited highlights that as global regulatory shifts accelerate, the large-scale application of AI in pharmaceuticals is rapidly advancing. It has...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLVI","VTHR","CHAT","03958","QTOC","BK1147","SBIO","ARTY","BK0028","BK4585","PBE","BK0188","LFSC","AGIX","BBP","WRND","GSKH","GDOC","BK0276","600958","BK1564","BK0012","IBB","BK0183","APXH","BIOY","BK4588","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658993909","title":"Press Release: Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2658993909","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658993909?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:01","pubTimestamp":1786366860,"startTime":"0","endTime":"0","summary":"Seasoned biotechnology founder, public company CFO and corporate strategist brings more than 25 years of leadership in oncology, capital markets, M&A and corporate governanceAppointment further streng","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RFL","BK4581","IBB","BK4233","IND","BK4585","SYNB","BK4539","BK4139","XBI","BBP","ERNA","LENZ","BK4588","BK4205","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658293667","title":"Alvotech to Report Financial Results for H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658293667","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658293667?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363200,"startTime":"0","endTime":"0","summary":"REYKJAVIK, Iceland, Aug.  10, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/10/3341796/0/en/alvotech-to-report-financial-results-for-h1-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBP","BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658960430","title":"Bio-Gene Technology Seeks ASX Quotation for 15.2 Million New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2658960430","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658960430?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:17","pubTimestamp":1786331840,"startTime":"0","endTime":"0","summary":"Bio-Gene Technology Ltd. ( ($AU:BGT) ) just unveiled an announcement. Bio-Gene Technology Ltd., an ASX-listed biotechnology company trading under t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bio-gene-technology-seeks-asx-quotation-for-15-2-million-new-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bio-gene-technology-seeks-asx-quotation-for-15-2-million-new-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XT","LNGR","RSPH","SYNB","FHLC","AGNG","JDOC","FWD","IEIH","IBB","DARP","BBP","BGT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642727","title":"Grail announces FDA advisory committee meeting to review Galleri test PMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642727","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642727?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115445,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","BK4588","FBT","GRAL","BK4129","IBRN","XBIX","PMA","SBIO","LABU","BK4139","BK4585","PBE","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657428836","title":"U.K. Short-Dated Sovereign Bonds Look More Attractive than Eurozone Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657428836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657428836?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:36","pubTimestamp":1786113360,"startTime":"0","endTime":"0","summary":"1436 GMT - U.K. short-term government bonds could outperform their eurozone counterparts, Bank of America strategists say in a note. The Bank of England looks less likely to increase interest rates in the near term given U.K.'s weak economic data, while the European Central Bank has a higher possibility of raising interest rates, the strategists say.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFUV","BBP","CLIX","PEVC","TACN","BAC","UCC","AVSD","CAOS","LRCY","ANEW","RJZ","ISVL","TSLP","IJK","KOMP","EPV","FXL","FXR","VAW","CGDV","BBEU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657243666","title":"Trump says rates should drop but it's not entirely up to Warsh","url":"https://stock-news.laohu8.com/highlight/detail?id=2657243666","media":"Ryan Chua / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657243666?lang=en_us&edition=fundamental","pubTime":"2026-08-07 11:53","pubTimestamp":1786074815,"startTime":"0","endTime":"0","summary":"President Donald Trump repeated his preference for lower interest rates but said it is not the Fed chief's decision alone, taking a much softer tone than the sharp criticisms he levelled at Powell.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/us-economy/trump-says-rates-should-drop-its-not-entirely-warsh?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/us-economy/trump-says-rates-should-drop-its-not-entirely-warsh?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["TSII","DFUV","RJZ","TSL","07766","TSLG","TSLL","TEST","TSDD","KOMP","TESL","IJK","TSLQ","TSLP","BK4585","LRCY","TSLO","CGDV","VAW","UCC","09366","TSLS","AVSD","TSLI","TSLT","FXL","TSYY","07366","TSLY","BBP","TLA","CLIX","09766","TSLR","CRSH","PEVC","BK4588","FXR","CAOS","ANEW","TSLZ","TSLW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657867667","title":"ArborGen cancels CEO long-term incentive shares after departure","url":"https://stock-news.laohu8.com/highlight/detail?id=2657867667","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657867667?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:49","pubTimestamp":1786063753,"startTime":"0","endTime":"0","summary":"ArborGen Holdings ( ($NZ:ARB) ) has issued an update. ArborGen Holdings Limited, a forestry and agricultural biotechnology company, provides geneti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arborgen-cancels-ceo-long-term-incentive-shares-after-departure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arborgen-cancels-ceo-long-term-incentive-shares-after-departure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","IBB","LNGR","BK4588","AGNG","XT","SYNB","BBP","IEIH","WOOD","BK4582","ARB","FWD","FHLC","BK4585","JDOC","DARP","IVEG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657050661","title":"Biogen completes acquisition of RayThera","url":"https://stock-news.laohu8.com/highlight/detail?id=2657050661","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657050661?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:55","pubTimestamp":1786056934,"startTime":"0","endTime":"0","summary":"Biogen (BIIB) announced the completion of the acquisition of RayThera Inc., a privately held biotechnology company focused on discovering and devel...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biogen-completes-acquisition-of-raythera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biogen-completes-acquisition-of-raythera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","BIIB","IE00B19Z9Z06.USD","FWD","BBP","LU0109394709.USD","FHLC","DARP","SYNB","IE00B894F039.SGD","IBB","BMED","BK4533","BK4139","IE00B19Z9P08.USD","PBE","JDOC","AGNG","LU0320765992.SGD","RSPH","XT","IEIH","LNGR","LU0889565916.HKD","BK4585","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657632642","title":"U.S. Interest Rates Could Stay Elevated Due to Heavy Debt Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2657632642","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657632642?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:27","pubTimestamp":1786022820,"startTime":"0","endTime":"0","summary":"1327 GMT - U.S. interest rates could remain high due to growing demand for funding by corporates and the government, Federated Hermes' R.J. Gallo says in a note. Rising debt issuance by AI-linked companies and persistently high borrowing from the U.S. government suggest that interest rates could stay elevated to attract capital, he says.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FXL","TSLP","TESL","AVSD","TSLO","TSLZ","BK4585","09766","TLA","TSLW","TSLL","DFUV","CGDV","TSYY","UCC","CLIX","FXR","LRCY","09366","07766","PEVC","IJK","TSLT","TEST","BK4588","TSLG","TSL","TSDD","TSLQ","TSII","TSLI","TSLS","ANEW","TSLR","BBP","TSLY","CAOS","VAW","CRSH","07366","KOMP","RJZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657023575","title":"Circio’s circVec gene therapy platform secures oral slot at top European ESGCT conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2657023575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657023575?lang=en_us&edition=fundamental","pubTime":"2026-08-06 13:45","pubTimestamp":1785995139,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) has shared an announcement. Circio Holding ASA, a biotechnology company specializing in circular RNA expression systems...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circios-circvec-gene-therapy-platform-secures-oral-slot-at-top-european-esgct-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circios-circvec-gene-therapy-platform-secures-oral-slot-at-top-european-esgct-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","BK4588","BBP","FBT","LFSC","BK4139","FHLC","DARP","RSPH","EPV","TBXU","LNGR","IBBQ","JDOC","FWD","IBB","CNCR","BK4585","IEIH","SYNB","IE0009354923.USD","RNA","XT","RDMX","AGNG","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657572786","title":"Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2657572786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657572786?lang=en_us&edition=fundamental","pubTime":"2026-08-06 07:25","pubTimestamp":1785972320,"startTime":"0","endTime":"0","summary":"The latest update is out from Takeda Pharmaceutical Co ( ($JP:4502) ). Takeda has secured U.S. FDA approval for ORZEYFUL, an oral orexin receptor 2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-first-in-class-u-s-approval-for-orexin-therapy-in-narcolepsy-type-1?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-first-in-class-u-s-approval-for-orexin-therapy-in-narcolepsy-type-1?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","LFSC","PINK","IDNA","GDOC","RSPH","XLVX","MRNY","GNMX","TBXU","BMED","PSCH","MRNX","IBB","BK4588","FRTY","TECB","MEDI","IEIH","IYH","BK4585","LABU","SYNB","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657543270","title":"Kevin Warsh has little to say about interest rates. But he has plenty to say about AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2657543270","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657543270?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:30","pubTimestamp":1785925825,"startTime":"0","endTime":"0","summary":"Federal Reserve Chairman Kevin Warsh has been outspoken about AI and its potential economic benefits. His view on where interest rates are heading, however, is harder to pin down.In the nine weeks since taking the helm at America’s central bank, Warsh has declined to publicly discuss what recent economic trends mean for rates, abandoning the long-held practice of providing “forward guidance.” He reinforced that approach last week after the Fed’s latest decision to hold its benchmark lending rate steady for the fifth consecutive time, saying it’s been “a change for the better.”Warsh has been much more forthcoming about AI. He said robust business investment, much of it driven by demand for AI infrastructure, “is preparing the ground for future growth.” He has also argued that AI could boost productivity and even lower inflation, which would give the Fed room to cut rates.When asked during last month’s congressional hearing if AI gives the Fed an opportunity to cut rates, Warsh said: “I ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cnn_highlight","url":"https://edition.cnn.com/2026/08/05/economy/kevin-warsh-fed-inflation-ai","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2026/08/05/economy/kevin-warsh-fed-inflation-ai","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["SHY","AGIX","IMF","BBP","TSLP","SCHO","UDN","UUP","BIL","VAW","ARTY","CLIX","LQD","TLTW","TMF","MUB","UCC","IEI","BND","IJK","PEVC","EDV","FXR","LRCY","ANEW","VTHR","MINT","CGDV","SHV","FAZ","BOXX","VGSH","UBT","AIPO","SKRE","VGLT","HYG","RJZ","TBT","GOVT","QTOC","AGG","AVSD","DFUV","FXL","VGIT","CHAT","KBE","CAOS","KOMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657924265","title":"Radiopharm Theranostics Lifts Cap on Securities Purchase Plan to AUD10 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657924265","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657924265?lang=en_us&edition=fundamental","pubTime":"2026-08-05 12:02","pubTimestamp":1785902537,"startTime":"0","endTime":"0","summary":"The latest update is out from Radiopharm Theranostics Limited ( ($AU:RAD) ). Radiopharm Theranostics Limited, an ASX-listed biotechnology company s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/radiopharm-theranostics-lifts-cap-on-securities-purchase-plan-to-aud10-million?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/radiopharm-theranostics-lifts-cap-on-securities-purchase-plan-to-aud10-million?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","DARP","IBB","LNGR","BK4585","RSPH","BBP","XT","JDOC","AGNG","SYNB","IEIH","FWD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657217591","title":"Actinogen Medical Seeks ASX Quotation for 3.5 Million Incentive Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2657217591","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657217591?lang=en_us&edition=fundamental","pubTime":"2026-08-05 10:57","pubTimestamp":1785898667,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has issued an announcement. Actinogen Medical Limited, an ASX-listed biotechnology company trading under the ticker...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-3-5-million-incentive-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-3-5-million-incentive-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","AGNG","BK4588","SYNB","LNGR","JDOC","DARP","IBB","BBP","RSPH","XT","BK4585","FHLC","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656508531","title":"Circio Strengthens Board With RNA Therapy Veterans Ahead of Clinical Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2656508531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656508531?lang=en_us&edition=fundamental","pubTime":"2026-08-04 17:32","pubTimestamp":1785835946,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA is a biotechnology developer of circular RNA-based gene express...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-strengthens-board-with-rna-therapy-veterans-ahead-of-clinical-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-strengthens-board-with-rna-therapy-veterans-ahead-of-clinical-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4588","JDOC","FHLC","LNGR","BK4139","SYNB","RNA","FWD","XT","BBP","IEIH","DARP","IE0009354923.USD","RSPH","BK4585","AGNG","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657952235","title":"Fed's Paulson says she keeps an 'open mind' on interest rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657952235","media":"Maria Eloisa Capurro / Bloomberg","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657952235?lang=en_us&edition=fundamental","pubTime":"2026-08-04 12:46","pubTimestamp":1785818782,"startTime":"0","endTime":"0","summary":"Federal Reserve Bank of Philadelphia president Anna Paulson said she will keep an open mind about the path for interest rates, focusing on the trends of underlying inflation.\n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/us-economy/feds-paulson-says-she-keeps-open-mind-interest-rates?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/us-economy/feds-paulson-says-she-keeps-open-mind-interest-rates?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["BOND","BSV","MINT","GOLY","TLH","UBT","TLTW","HYG","BND","GOVT","TBT","NGHT","TYO","UUP","DFUV","FAZ","VCSH","ANEW","VGSH","BIL","ZROZ","FXL","TBIL","VCIT","TIP","CLIX","TMF","BBP","PBDC","CAOS","KBE","LQD","VGLT","USHY","GBIL","SKRE","EDV","SCHO","SHV","MUB","AVSD","IEI","UDN","CGDV","VGIT","AGG","SHY","BOXX","JPST","DBND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300172","title":"Eikon Therapeutics Announces Recent Board Director Resignations","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300172","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300172?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:32","pubTimestamp":1785796348,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics, Inc. ( ($EIKN) ) has provided an announcement. On July 31, 2026, Eikon Therapeutics, Inc., a biotechnology company focused on d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eikon-therapeutics-announces-recent-board-director-resignations?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eikon-therapeutics-announces-recent-board-director-resignations?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BBP","BK4588","SYNB","AGNG","EIKN","IBB","DARP","JDOC","FWD","LNGR","RSPH","IEIH","FHLC","XT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656304376","title":"Fresenius announces FDA approval of rituximab biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2656304376","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656304376?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:15","pubTimestamp":1785788150,"startTime":"0","endTime":"0","summary":"Fresenius Kabi, an operating company of Fresenius (FSNUY), announced that the U.S. Food and Drug Administration has approved a rituximab biosimilar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fresenius-announces-fda-approval-of-rituximab-biosimilar-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fresenius-announces-fda-approval-of-rituximab-biosimilar-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","FRTY","MRNX","BK4196","TECB","BK4585","IDNA","IEIH","GDOC","IYH","BMED","LFSC","PSCH","RSPH","NVIB","IBB","BK4588","PINK","MEDI","TBXU","BBP","SYNB","LABU","FSNUY","XLVX","MRNY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":162,"code":"91000000","status":"200"}]}}